| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.007 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |